Literature DB >> 24977029

Chinese expert consensus on bronchial asthma control.

.   

Abstract

Year:  2014        PMID： 24977029      PMCID： PMC4073379          DOI： 10.3978/j.issn.2072-1439.2014.06.25

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up.

Authors:  Barrett T Kitch; A David Paltiel; Karen M Kuntz; Douglas W Dockery; Jan P Schouten; Scott T Weiss; Anne L Fuhlbrigge
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

2.  Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study.

Authors:  E D Bateman; J Bousquet; W W Busse; T J H Clark; N Gul; M Gibbs; S Pedersen
Journal:  Allergy       Date:  2008-07       Impact factor: 13.146

3.  Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.

Authors:  Klaus F Rabe; Tito Atienza; Pál Magyar; Per Larsson; Carin Jorup; Umesh G Lalloo
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

4.  Measuring asthma control: a comparison of three classification systems.

Authors:  P M O'Byrne; H K Reddel; G Eriksson; O Ostlund; S Peterson; M R Sears; C Jenkins; M Humbert; R Buhl; T W Harrison; S Quirce; E D Bateman
Journal:  Eur Respir J       Date:  2010-01-28       Impact factor: 16.671

5.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.

Authors:  Paul M O'Byrne; Hans Bisgaard; Philippe P Godard; Massimo Pistolesi; Mona Palmqvist; Yuanjue Zhu; Tommy Ekström; Eric D Bateman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-22       Impact factor: 21.405

6.  Effect of different asthma treatments on risk of cold-related exacerbations.

Authors:  H K Reddel; C Jenkins; S Quirce; M R Sears; E D Bateman; P M O'Byrne; M Humbert; R Buhl; T Harrison; G G Brusselle; A Thorén; U Sjöbring; S Peterson; O Ostlund; G S Eriksson
Journal:  Eur Respir J       Date:  2011-03-15       Impact factor: 16.671

7.  Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.

Authors:  R Scicchitano; R Aalbers; D Ukena; A Manjra; L Fouquert; S Centanni; L-P Boulet; I P Naya; C Hultquist
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

8.  Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey.

Authors:  Stephen P Peters; Craig A Jones; Tmirah Haselkorn; David R Mink; David J Valacer; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

9.  Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.

Authors:  Jean Bousquet; Louis-Philippe Boulet; Matthew J Peters; Helgo Magnussen; Joaquin Quiralte; Nora E Martinez-Aguilar; Asa Carlsheimer
Journal:  Respir Med       Date:  2007-10-01       Impact factor: 3.415

10.  Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

Authors:  P Kuna; M J Peters; A I Manjra; C Jorup; I P Naya; N E Martínez-Jimenez; R Buhl
Journal:  Int J Clin Pract       Date:  2007-03-16       Impact factor: 2.503
View more
  1 in total

1.  INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatment.

Authors:  Jiangtao Lin; Xiuhua Fu; Ping Jiang; Weidong Song; Xiaoyun Hu; Zhijun Jie; Chuntao Liu; Zhengguang He; Xiangdong Zhou; Huaping Tang
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.